NEW YORK – A team from the US, France, and Sweden has started untangling the cancer genome in the context of TP53 mutations, integrating genomic data for tens of thousands of tumors to assess TP53 interactions in a pan-cancer setting. As they reported ...
from Google Alert - health https://ift.tt/2T27svT
via IFTTT
0 comments:
Post a Comment